Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Makes Three, Not Two, Investments In AFib Ablation

This article was originally published in The Gray Sheet

Executive Summary

Abbott made a minority equity investment in VytronUS as part of the startup's latest funding round, according to the VytronUS' biggest institutional investor. That comes in addition to an acquisition and a right-to-purchase transaction for two other atrial fibrillation ablation firms, marking Abbott's entry into that market.

You may also be interested in...



Abbott Enters Electrophysiology Fray With Topera, ACT Deals

The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.

VytronUS Raises Funds, Loses CEO To New Abbott EP Biz

The cardiac arrhythmia ablation device firm raised $31.6 million in a Series B financing, the same day its CEO was announced to be leaving for Abbott's new electrophysiology unit.

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel